Glenmark Life Sciences Share Price (ALIVUS)
as on
| Source : NSE
Glenmark Life Sciences Stock Performance
as on August 26, 2025 at 4:01 pm IST
Day's Low
Day's High
₹943.9₹973
0.48%
Downside
2.58%
Upside
52 Week's Low
52 Week's High
₹850₹1,335.110.38%
Downside
40.76%
Upside
| Market Stats | |
| Previous Close | ₹970.00 |
| Open | ₹960.30 |
| Volume | 1.22L |
| Upper Circuit | ₹1,164.00 |
| Lower Circuit | ₹776.00 |
| Day's Low | ₹943.9 |
| Day's High | ₹973 |
| 52 Week Low | ₹850 |
| 52 Week High | ₹1,335.1 |
| Returns % | |
| 1 Month Return | -7.19 % |
| 3 Month Return | -12.27 % |
| 1 Year Return | -6.81 % |
| 3 Year Return | + 115.89 % |
| 5 Year Return | + 26.72 % |
Glenmark Life Sciences Stock Fundamentals & Key Indicators
Check Glenmark Life Sciences market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹11,631.37 Cr
Return on Equity (ROE)
18.86
PE Ratio (TTM)
0Return on capital employed (ROCE)
24.97
Beta (LTM)
0.74
P/B Ratio
4.7
Dividend Yield
0PEG Ratio
0Quarterly Earnings Growth YOY
9.02
EPS (TTM)
0Sector
Pharmaceuticals
Book Value
0Technical Analysis
Bearish
View Technical Analysis
Glenmark Life Sciences Stock's Interest Amongst Investors
Glenmark Life Sciences Stock Recommendation
Get updated buy, sell, and hold recommendations by analysts on Glenmark Life Sciences.
based on 4 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
100% of analysts recommend a 'BUY' rating for Glenmark Life Sciences. Average target price of ₹1266
Source: S&P Global Market Intelligence
Glenmark Life Sciences Share Price Target
Get share price movements and forecasts by analysts on Glenmark Life Sciences.
Glenmark Life Sciences price forecast by 4 analysts
Upside of33.47%
High
₹1382
Target
₹1266.00
Low
₹1150
Glenmark Life Sciences target price ₹1266, a slight upside of 33.47% compared to current price of ₹948.5. According to 4 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Glenmark Life Sciences revenue growth forecast
Expected growth rate Q1, FY2027:0
Forecast
Actual
Including amortisation and stock based compensations
Glenmark Life Sciences EPS growth forecast
EPS estimate Q1, FY2027:0
Forecast
Actual
Source: S&P Global Market Intelligence
Alivus Life Sciences Ltd Financial Results
Get the annual and quarterly financial summary of Alivus Life Sciences Ltd, including revenue, profit, loss and more.
Glenmark Life Sciences Earnings and Dividends
View detailed summary of the earnings and dividend history of Glenmark Life Sciences.
Alivus Life Sciences Ltd Earnings Results
Alivus Life Sciences Ltd’s net profit jumped 9.02% since last year same period to ₹121.54Cr in the Q1 2025-2026. On a quarterly growth basis, Alivus Life Sciences Ltd has generated -14.33% fall in its net profits since last 3-months.
Read More about Earnings ResultsAlivus Life Sciences Ltd Dividends October,2023
In the quarter ending September 2023, Alivus Life Sciences Ltd has declared dividend of ₹22.50 per share on 09 Oct 2023 - translating a dividend yield of 4.59%.
Read More about Dividends
Indices Featuring Glenmark Life Sciences Stock
Check stock indices that include Glenmark Life Sciences.
Glenmark Life Sciences Stock Shareholding Pattern
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Glenmark Life Sciences.
| Investors | Holdings % | Quarterly Trend | 3M change |
|---|---|---|---|
| Promoter Holdings | 74.94% | ||
| Foreign Institutions | 6.42% | ||
| Mutual Funds | 4.06% | 12.89 | |
| Retail Investors | 13.03% | ||
| Others | 1.56% |
Alivus Life Sciences Ltd vs Peers
Compare market cap, revenue, PE, and other key metrics of Glenmark Life Sciences with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| BUY | 11,631.37 | 5.34% | 0.00 | 485 | 2,386 | |
| NA | 8.81 | 39.65% | 0.00 | -1 | 1 | |
| NA | 31.22 | -5.34% | 0.00 | 1 | 150 | |
| NA | 3,779.96 | 64.71% | 0.70 | 86 | 806 | |
| HOLD | 31,756.80 | 1.19% | 0.53 | 698 | 5,616 |
Insights on Alivus Life Sciences Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTMF Holding Up
Mutual Funds have increased holdings from 3.59% to 4.06% in Jun 2025 quarter
NO EFFECTAgainst Peers
In the last 1 year, Divis Laboratories Ltd has given 26.3% return, outperforming this stock by 33.1%
- NO EFFECT
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 133.9% return, outperforming this stock by 18.0%
NEGATIVE IMPACTRetail Holding Down
Retail Investor have decreased holdings from 13.25% to 13.03% in Jun 2025 quarter
- NEGATIVE IMPACT
Price Dip
In the last 1 month, ALIVUS stock has moved down by -7.2%
- NEGATIVE IMPACT
FII Holding Down
Foreign Institutions have decreased holdings from 6.57% to 6.42% in Jun 2025 quarter
- NEGATIVE IMPACT
Promoter Holding Down
Promoters have decreased holdings from 74.99% to 74.94% in Jun 2025 quarter
About Alivus Life Sciences Ltd
Revenue: ₹601.85Cr as on June 2025 (Q1 FY26)
Net Profit: ₹121.54Cr as on June 2025 (Q1 FY26)
Listing date: 06 Aug, 2021
Chairperson Name: Glenn Saldanha
| Organisation | Alivus Life Sciences Ltd |
| Industry | Pharmaceuticals |
| CEO | Glenn Saldanha |
| E-voting on shares | Click here to vote |
Mutual Funds that own Glenmark Life Sciences Stock
Check out the Mutual Funds with significant holdings in Glenmark Life Sciences.
FAQs
What is Glenmark Life Sciences share price today?
Glenmark Life Sciences share price today stands at ₹948.5, Open: ₹960.3, Previous Close: ₹970, High: ₹973, Low: ₹943.9, 52 Week High: ₹1335.1, 52 Week Low: ₹850 as on .
How to buy Glenmark Life Sciences shares ?
To buy Glenmark Life Sciences shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for ALIVUS or Alivus Life Sciences Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Glenmark Life Sciences shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is today's traded volume of Glenmark Life Sciences?
Today's traded volume of Glenmark Life Sciences is 1.22L. Which means that 1.22L shares of Glenmark Life Sciences were bought and sold on the stock market during today's trading session.
What is Glenmark Life Sciences's market cap today?
Today's market capitalisation of Glenmark Life Sciences is ₹11,631.37 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
What is the 52 week high and 52 week low range of Glenmark Life Sciences?
Glenmark Life Sciences’s 52 week high is ₹1335.1 and 52 week low is ₹850. The current share price of Glenmark Life Sciences is ₹948.5, which is -28.96% down from its 52 week high and 11.59% up from its 52 week low.